Scholarlink

Peripheral blood stem cell transplantation (PBSCT) is an indispensable treatment option for progressive malignant diseases. Autologous PBSCT (auto-PBSCT) is usually performed on patients with malignant disease without residual malignant cells in bone marrow. Allogeneic PBSCT (allo-PBSCT) is usually performed on patients with progressive hematological malignancies. In 2022, a total of 976 related and 310 unrelated allo-PBSCT procedures were performed in Japan.

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Peripheral Blood Stem Cell Transplantation

  • 章节

  • 发表日期：

    2026年

查看全文
  • Rie Yamazaki,
  • Naoko Watanabe-Okochi

摘要

Peripheral blood stem cell transplantation (PBSCT) is an indispensable treatment option for progressive malignant diseases. Autologous PBSCT (auto-PBSCT) is usually performed on patients with malignant disease without residual malignant cells in bone marrow. Allogeneic PBSCT (allo-PBSCT) is usually performed on patients with progressive hematological malignancies. In 2022, a total of 976 related and 310 unrelated allo-PBSCT procedures were performed in Japan.